These emerging therapies , Retatrutide, represent a groundbreaking advancement in managing obesity and potentially other conditions . They all are grouped as GLP-1 receptor activators , indicating these substances to mimic the natural GLP-1 peptide, stimulating metabolic secretion and reducing hu